Bmab 1000

BIOLOGICAL2 trials

Sponsors

Biocon Biologics UK Ltd

Conditions

Healthy VolunteersPostmenopausal Women With Osteoporosis

Phase 1

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS

CompletedNCT05323708

Biocon Biologics UK LtdHealthy Volunteers

Start: 2022-03-09End: 2023-10-06Updated: 2024-04-17

Phase 3

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis

CompletedNCT05345691

Biocon Biologics UK LtdPostmenopausal Women With Osteoporosis

Start: 2022-05-24End: 2024-06-12Updated: 2025-09-09